EMBL-EBI | Chemical Biology Resources | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
CHEBI:31653 - glafenine
| Formula | C19H17ClN2O4 |
| Net Charge | 0 |
| Average Mass | 372.808 |
| Monoisotopic Mass | 372.08768 |
| SMILES | O=C(OCC(O)CO)c1ccccc1Nc1ccnc2cc(Cl)ccc12 |
| InChI | InChI=1S/C19H17ClN2O4/c20-12-5-6-14-17(7-8-21-18(14)9-12)22-16-4-2-1-3-15(16)19(25)26-11-13(24)10-23/h1-9,13,23-24H,10-11H2,(H,21,22) |
| InChIKey | GWOFUCIGLDBNKM-UHFFFAOYSA-N |
| Wikipedia |
|---|
| Roles Classification |
|---|
| Chemical Role: | Bronsted base A molecular entity capable of accepting a hydron from a donor (Brønsted acid). |
| Biological Roles: | analgesic An agent capable of relieving pain without the loss of consciousness or without producing anaesthesia. In addition, analgesic is a role played by a compound which is exhibited by a capability to cause a reduction of pain symptoms. non-narcotic analgesic A drug that has principally analgesic, antipyretic and anti-inflammatory actions. Non-narcotic analgesics do not bind to opioid receptors. inhibitor A substance that diminishes the rate of a chemical reaction. |
| Applications: | non-steroidal anti-inflammatory drug An anti-inflammatory drug that is not a steroid. In addition to anti-inflammatory actions, non-steroidal anti-inflammatory drugs have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. analgesic An agent capable of relieving pain without the loss of consciousness or without producing anaesthesia. In addition, analgesic is a role played by a compound which is exhibited by a capability to cause a reduction of pain symptoms. non-narcotic analgesic A drug that has principally analgesic, antipyretic and anti-inflammatory actions. Non-narcotic analgesics do not bind to opioid receptors. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| glafenine (CHEBI:31653) has functional parent anthranilic acid (CHEBI:30754) |
| glafenine (CHEBI:31653) has functional parent glycerol (CHEBI:17754) |
| glafenine (CHEBI:31653) has role analgesic (CHEBI:35480) |
| glafenine (CHEBI:31653) has role inhibitor (CHEBI:35222) |
| glafenine (CHEBI:31653) has role non-narcotic analgesic (CHEBI:35481) |
| glafenine (CHEBI:31653) has role non-steroidal anti-inflammatory drug (CHEBI:35475) |
| glafenine (CHEBI:31653) is a aminoquinoline (CHEBI:36709) |
| glafenine (CHEBI:31653) is a carboxylic ester (CHEBI:33308) |
| glafenine (CHEBI:31653) is a glycol (CHEBI:13643) |
| glafenine (CHEBI:31653) is a organochlorine compound (CHEBI:36683) |
| glafenine (CHEBI:31653) is a secondary amino compound (CHEBI:50995) |
| IUPAC Name |
|---|
| 2,3-dihydroxypropyl 2-[(7-chloroquinolin-4-yl)amino]benzoate |
| INNs | Source |
|---|---|
| glafenina | ChemIDplus |
| glafenine | KEGG DRUG |
| glafénine | WHO MedNet |
| glafeninum | ChemIDplus |
| Synonyms | Source |
|---|---|
| 2,3-Dihydroxypropyl N-(7-chloro-4-quinolyl) anthranilate | ChemIDplus |
| 4-(2'-beta,gamma-Dihydroxypropoxycarbonylphenylamino)-7-chloroquinoline | ChemIDplus |
| 4-((2-Carboxyphenyl)amino)-7-chloroquinoline alpha-monoglyceride | ChemIDplus |
| Glafenin | ChemIDplus |
| Glaphenin | ChemIDplus |
| Glaphenine | ChemIDplus |
| Citations |
|---|